What is Alleva?
Founded in 2016 and headquartered in Laguna Niguel, California, Alleva provides a comprehensive, fully-featured software suite tailored for healthcare agencies and small-to-medium enterprises. By offering end-to-end solutions optimized for Windows environments, the company addresses critical operational inefficiencies in clinical management and administrative workflows. Its market position is defined by a commitment to streamlining complex healthcare delivery processes, enabling providers to focus on patient outcomes rather than technical overhead. As a specialized B2B SaaS provider, Alleva has carved out a distinct niche by integrating clinical documentation, billing, and compliance into a unified, scalable architecture.
How much funding has Alleva raised?
Alleva has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2022): $12M with participation from Ankona Capital
Key Investors in Alleva
Ankona Capital
Ankona Capital is a Southern California-based growth venture firm that specializes in early growth-stage B2B software companies, providing both capital and operational expertise to foster long-term success.
What's next for Alleva?
With the recent influx of capital, Alleva is well-positioned to transition from its current growth phase into a broader enterprise-level scaling strategy. The company is expected to leverage this investment to enhance its product feature set, potentially integrating advanced analytics and AI-driven clinical decision support tools. Furthermore, the strategic backing from institutional partners suggests a focus on expanding its footprint beyond its current regional stronghold. As the healthcare industry continues to undergo rapid digital transformation, Alleva's ability to maintain its operational agility while scaling its infrastructure will be the primary determinant of its long-term market dominance and potential for future liquidity events.
See full Alleva company page
